Gordon Findlay, an executive at Novo Nordisk, collapsed in the Oval Office on Thursday afternoon. This incident occurred while President Trump was announcing a plan to reduce the prices of weight-loss drugs, including Ozempic.
Findlay received immediate medical assistance and was helped back to his feet. Officials expect him to recover without serious complications.
The collapse happened as the President outlined policies aimed at making weight-loss medications more affordable.
"Gordon Findlay of Novo Nordisk collapsed in the Oval Office Thursday afternoon as President Trump announced a plan to reduce the price of weight-loss drugs, including Ozempic."
Medical aid was promptly provided, and Findlay is expected to be fine according to available updates.
"Findlay was helped to his feet, given medical assistance and is expected to be fine."
Reported by Jodi Leese Glusco on November 6, 2025.
Author's summary: A Novo Nordisk executive briefly collapsed during a key Oval Office announcement on weight-loss drug pricing, but received prompt care and is expected to recover fully.